All locations are open. Call your doctor today to schedule an in-person appointment or a doctor video visit.
Learn about our COVID-SAFE Care • Latest Visitor Policy and Service Updates • Donate and Lend Support


Todos los centros abiertos. Llame al médico hoy para una cita en persona o para una video visita médica.
Sepa qué es la Salud A SALVO DE COVID • Novedades de servicios y normas de visitas • Done y dé apoyo

Learn more
Espanol
Tertiary Hyperparathyroidism
Home >  Cancer (Oncology) >  Diseases and Conditions >  Endocrine/Neuroendocrine Tumors >  Parathyroid Disorders >  Tertiary Hyperparathyroidism
Print

Diseases and Conditions

Tertiary Hyperparathyroidism

Tertiary hyperparathyroidism occurs in patients that have undergone kidney transplantation for kidney failure. These patients have developed secondary hyperparathyroidism prior to receiving the kidney transplant.

Typically, hyperparathyroidism will resolve over the first year following kidney transplantation, as the new kidney can adequately control calcium and phosphorus excretion in the urine and, over time, the parathyroid glands begin to function normally again. In some patients this does not occur and the parathyroid glands continue to function abnormally despite normal kidney function, a condition termed tertiary hyperparathyroidism.

Similarly to treatment for secondary hyperparathyroidism, treatment for tertiary hyperparathyroidism involves removing most of the parathyroid glands. A small portion of parathyroid tissue is preserved to regulate calcium levels following surgery.

The Endocrine and Neuroendocrine Tumor Program treats tertiary hyperparathyroidism using the most advanced technologies and treatments available.